Cochrane Renal Group

Topic list

Acute Renal Failure | Chronic Kidney Disease | Diagnostic Tests
Drugs and the Kidney | End-Stage Kidney Disease | General Nephropathy
Process of Care |Transplantation | Urinary Tract Infection | Urology

ACUTE RENAL FAILURE

  • Prevention
    • Antihypertensive agents
      • Antihypertensive agents for preventing acute renal failure
    • Contrast-induced nephropathy
    • Diuretics for acute renal failure
    • Haemolytic uraemic syndrome
    • Plasma volume expanders
      • Plasma volume expanders for preventing acute renal failure
    • Surgical patients
      • Interventions for preventing acute renal failure in surgical patients
        • Antihypertensive agents for protecting renal function in surgical patients
  • Treatment
    • Dialysis
      • Haemodialysis for acute renal failure
        • Frequency
        • Membranes
        • Haemodialysis solutions
      • Dialysis solutions for acute renal failure
      • Peritoneal dialysis for acute renal failure
      • Intermittent versus continuous renal replacement therapy for acute renal failure
      • Continuous veno-venous haemofiltration (CVVH) for acute renal failure
      • Continuous veno-venous haemofiltration (CVVH) for treating paraquat poisoning
    • Atrial natriuretic peptide for acute renal failure
    • Nutritional support for acute renal failure
    • Haemolytic uraemic syndrome
    • Hyperkalaemia
    • Sodium bicarbonate supplements for acute renal failure

DIAGNOSTIC TESTS

  • Acute pyelonephritis
  • Cytomegalovirus (CMV) diagnostic tests
  • Iron measurements
  • Renal scarring
  • Suprapubic urine aspiration
  • Ureteric colic

DRUGS AND THE KIDNEY

  • Amphotericin B deoxycholate
  • Nonsteroidal anti-inflammatory drugs

CHRONIC KIDNEY DISEASE

  • Acidosis control
  • Anaemia control
    • Androgens for the anaemia of chronic kidney disease
    • Darbepoetin for the anaemia of chronic kidney disease
    • Erythropoietin
    • Haemoglobin and haematocrit targets
  • Antihypertensive agents
  • Cardiovascular protection
    • Interventions for preventing cardiovascular death in chronic kidney disease
  • Cholesterol management
    • Interventions for lowering cholesterol in pre-dialysis patients
  • Exercise
  • Growth hormone
  • Hyperhomocysteinaemia
    • Interventions for hyperhomcysteinaemia in pre-dialysis patients
    • Infection
    • Interventions for preventing chickenpox (varicella) in children with chronic kidney disease
  • Interventions for preventing the progression of chronic kidney disease
    • Antihypertensive agents
    • Dietary interventions
      • L-arginine
      • Oral absorbents
      • Protein restriction
    • Ibopamine for preventing the progression of chronic kidney disease
  • Nutritional supplements
    • Levocarnitine for chronic kidney disease
    • Interventions for malnutrition in chronic kidney disease
  • Renal bone disease
    • Interventions for preventing renal bone disease in chronic kidney disease

END-STAGE KIDNEY DISEASE

  • GENERAL MANAGEMENT
    • Anabolic steroids
    • Anaemia control
      • Darbepoetin
      • Erythropioetin
      • Iron supplements
    • Blood pressure control
      • Hypertension
      • Hypotension
    • Cardiovascular
    • Cholesterol management
      • Dietary interventions for lowering cholesterol in dialysis patients
      • Medical Interventions
    • Depression
    • Hyperalbuminaemia
    • Hyperkalaemia
    • Itching
    • Nutritional supplements
    • Renal function
      • Interventions for improving renal function in end-stage kidney disease
    • Sexual dysfunction
      • Erectile dysfunction
    • Treatment options
  • HAEMODIALYSIS
    • Access
      • Catheters
      • Contrast agents for haemodialysis access
      • Needling devices
      • Vascular access
    • Dialysate
      • Solutions
      • Dialysate purity
    • Dialysers
      • Membranes
      • Flux
      • Dialyser reuse
      • Dual dialysers
      • Ultrafiltration control
    • Dose/Duration
      • Automated versus standard ultrafiltration for haemodialysis
      • Kt/v and creatinine clearance targets
      • Short versus standard duration haemodialysis
    • Infection
      • Exit site and tunnel infections
      • Bacteraemia
    • Other
      • Erythropoietin
      • Fluid control
      • Interventions for hyperhomocysteinaemia in haemodialysis patients (Registered title KP082)
      • Interventions for preventing and treating cramps during haemodialysis
      • Interventions for preventing dialysis-related hypotension
      • Interventions for treating restless leg syndrome in haemodialysis patients (Registered title KW017)
      • Interventions for treating elevated ferritin levels in haemodialysis patients
      • Iron for long-term haemodialysis patients
      • Vitamin C infusions
    • Thrombosis/Patency
      • Anticoagulation
      • Interventions for preventing haemodialysis access blockage
      • Interventions for preventing clotting of extracorporeal circuits
      • Interventions for preventing thrombosis in haemodialysis grafts
      • Priming solutions for haemodialysis
      • Prophylactic angioplasty for extending patency in haemodialysis grafts
      • Surgical versus endovascular management of thrombosed dialysis access grafts
    • Treatment options
      • Conventional versus nocturnal haemodialysis for end-stage kidney disease
      • Home versus in-centre haemodialysis
  • PERITONEAL DIALYSIS
    • Access
      • Catheter insertion techniques
      • Catheter placement
      • Tenckhoff catheter configuration
      • Transfer systems
    • Anticoagulation
      • Wafarin for continuous ambulatory peritoneal dialysis
    • Dialysate
      • Dialysis solutions
      • Exchange volumes
    • Dose/Duration
      • Clearance targets
    • Infection
    • Other
      • Interventions for improving nutritional status
      • Interventions for preserving residual kidney function
      • Interventions for preventing acidosis
    • Treatment options

GENERAL NEPHROLOGY

  • GLOMERULAR DISEASES
    • Diabetic kidney disease
      • Diabetic education programmes for dialysis patients
      • Glycosaminoglycan for preventing and treating diabetic kidney disease
      • Salt diets for preventing and treating diabetic kidney disease
      • Antihypertensive agents
    • Focal glomerulosclerosis
      • Antihypertensive agents
      • Immunosuppressive agents
    • Henoch-Schonlein purpura
      • Interventions for preventing renal complications in Henoch-Schonlein purpura
    • IgA nephropathy
    • Lupus nephritis
      • Treatment
    • Membranoproliferative glomerulonephritis
    • Membranous nephopathy
    • Minimal-change nephroapathy
      • Treatment
        • Non-corticosteroid treatment
        • Corticosteroid treatment
    • Nephrotic Syndrome
      • Diuretics
      • Infection
      • Interventions for preventing thrombosis
      • Lipid-lowering agents
      • Treatment
    • Rapidly progressive glomerulonephritis
      • Treatment
    • KIDNEY BIOPSIES
    • GENETIC DISORDERS
      • Nephropathic cystinosis
      • Polycystic kidney disease
        • Blood pressure control
        • Cholesterol management

PROCESS OF CARE

  • TRANSPLANTATION
    • Medication compliance
  • URINARY TRACT INFECTION
    • Telephone versus in-office management
  • END-STAGE KIDNEY DISEASE
    • Blood pressure control in haemodialysis patients

TRANSPLANTATION

  • KIDNEY
    • Antihypertensive agents
      • Antihypertensive agents
      • Calcium antagonists
      • Diuretics
    • Antiplatelet activating factor
    • Atrial natriuretic peptide
    • Bone disease
    • Cholesterol management
    • Erythrocytosis
    • General care
    • Immunosuppression
      • Antibody immunosuppression
        • Monoclonal - Interleukin 2 receptor antagonists
        • Polyclonal
      • Azathioprine
      • Corticosteroids
        • Steroid withdrawal
        • Steroid tapering
        • Low versus high dose steroids
      • Cyclosporin
      • Double versus triple therapy
      • FTY720
      • Mizoribine
      • Mycophenolate mofetil
      • Sirolimus
      • Tacrolimus
    • Infection
      • Interventions for preventing pneumocystis pneumonia in kidney transplant recipients
    • Hyperhomocysteinaemia
    • Nutritional supplements
      • Fish oil
      • L-arginine
      • immunonutrients
      • Vitamin C
    • Pentoxifylline
    • Renal bone disease
      • Phosphate replacement therapy
    • Urological complications
  • KIDNEY AND OTHER SOLID ORGANS
    • Antibiotics
    • KIDNEY-PANCREAS
      • Immunosuppression
        • Antibody immunosuppression
        • Corticosteroids
        • Tacrolimus
      • Donor-organ preservation
    • INFECTION
      • Cytomegalovirus (CMV)
      • Fungal infections
  • SURGERY TECHNIQUES
    • Antibiotics
    • Anticoagulants
    • Blood transfusions
      • Donor-specific
      • Recipient
    • Donor organ preservation techniques
    • Surgical techniques
      • Single versus simultaneous-double kidney transplantation

URINARY TRACT INFECTION

  • Prevention
    • Lower urinary tract infection
    • Pyelonephritis
    • Urinary tract infection - kidney transplant recipients
    • Urologic investigations
  • Treatment
    • Asymptomatic urinary tract infection
    • Lower urinary tract infection
    • Pyelonephritis
  • Urine collection
    • Interventions for collecting urine samples

UROLOGY

  • RENAL COLIC
    • Prevention
    • Treatment
      • Acupuncture
      • Agonist-antagonists
      • Glucagon
      • Nitrates
      • Non-opiate analgesia
      • Nonsteroidal anti-inflammatory drugs
      • Prostaglandin inhibitors
  • KIDNEY STONES
    • Idipathic hypercalciuria
    • Prevention
      • Water intake
    • Treatment
      • Extra-corporeal shock wave lithotripsy
        • Diuresis
        • Peri-operative stenting
        • Pain relief
      • Interventions for hypercalciuria
      • IV fluids
  • URINARY TRACT DILATATION
  • VESICOURETERAL REFLUX
    • Treatment
  • UROLOGICAL PROCEDURES

Working for Cochrane renal group

nephrology series

podcasts
Listen to a podcast of
Cranberries for preventing urinary tract infections


A subscription may be required if accessing outside Australia.

Introduction to writing
a Cochrane systematic review:
Sydney workshops 2-4 July 2014 & 10-12 December 2014
[Details]

Other workshop details

 

Help us with our Renal Trials Register

Do you have conference proceedings [books or cd-roms] that you no longer need or could lend to us for hadsearching? If so, email Ruth Mitchell for details

Handsearching

Are you interested in helping us handsearch journals or conference proceedings. To find out more about our handsearching activities, email Ruth Mitchell